Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Fortrea Clinical Research Unit, Daytona Beach, Florida Clinical Pharmacology of Miami, Miami, Florida Fortrea Clinical Research Unit, Dallas, Texas Endeavor Clinical Trials, San Antonio, Texas Singapore
Lilly Centre for Clinical Pharmacology, Singapore